Ivosidenib (IVO; AG-120) in IDH1-mutant newly-diagnosed acute myeloid leukemia (ND AML): Updated results from a phase 1 study Meeting Abstract
| Authors: | Roboz, G. J.; Dinardo, C. D.; Stein, E. M.; de Botton, S.; Mims, A. S.; Prince, G. T.; Altman, J. K.; Arellano, M. L.; Erba, H. P.; Pollyea, D. A.; Stein, A. S.; Watts, J. M.; Fathi, A. T.; Kantarjian, H. M.; Tallman, M. S.; Fan, B.; Liu, H.; Wu, B.; Attar, E. C.; Stone, R. M. |
| Abstract Title: | Ivosidenib (IVO; AG-120) in IDH1-mutant newly-diagnosed acute myeloid leukemia (ND AML): Updated results from a phase 1 study |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 412s |
| Language: | English |
| ACCESSION: | WOS:000487345806229 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.7028 |
| Notes: | Meeting Abstract: 7028 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work